AbCellera Biologics (ABCL) EBITDA Margin (QoQ) (2020 - 2026)
AbCellera Biologics (ABCL) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
AbCellera Biologics |
1.55 Bn |
1.44 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-47,393.00 |
| Dec 31, 2025 |
61,494.00 |
| Sep 30, 2025 |
-46,044.00 |
| Jun 30, 2025 |
96,124.00 |
| Mar 31, 2025 |
-39,938.00 |
| Dec 31, 2024 |
3,277.00 |
| Sep 30, 2024 |
-26,468.00 |
| Jun 30, 2024 |
-9,887.00 |
| Mar 31, 2024 |
10,756.00 |
| Dec 31, 2023 |
-8,961.00 |
| Sep 30, 2023 |
-12,453.00 |
| Jun 30, 2023 |
3,179.00 |
| Mar 31, 2023 |
-19,228.00 |
| Dec 31, 2022 |
-16,686.00 |
| Sep 30, 2022 |
4,022.00 |
| Jun 30, 2022 |
-6,864.00 |
| Mar 31, 2022 |
1,064.00 |
| Dec 31, 2021 |
45,831.00 |
| Sep 30, 2021 |
-41,492.00 |
| Jun 30, 2021 |
-5,844.00 |
